BMC Cancer

official impact factor 3.15

Open Access Highly Access Research article

Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia

Mitch Raponi1*, Robert T Belly1, Judith E Karp2, Jeffrey E Lancet3, David Atkins1 and Yixin Wang1

Author Affiliations

1 Veridex, LLC, a Johnson and Johnson company, San Diego, CA 9212, USA

2 The Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA

3 University of Rochester Cancer Center, Rochester, NY 14642, USA

For all author emails, please log on.

BMC Cancer 2004, 4:56 doi:10.1186/1471-2407-4-56

Published: 25 August 2004

Additional files

Additional File 1:

A. Two-way hierarchical clustering of 1198 genes regulated in three AML cell lines after tipifarnib treatment. A fold-change ratio was calculated using the treated sample and its matched untreated sample. B. Gene expression changes in patient AML cells. Two-way hierarchical clustering of 1016 genes regulated in two AML patients over a three-week time course.

Format: DOC Size: 191KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional File 2:

A list of 141 genes with known function that were regulated in both the cell line and patient data sets.

Format: XLS Size: 32KB Download file

This file can be viewed with: Microsoft Excel Viewer

Open Data